Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has issued an update.
China NT Pharma Group Co., Ltd. has issued a clarification regarding its acquisition of 100% of the issued shares in target companies, involving the issuance of consideration shares under a specific mandate. The company corrected financial figures for its PRC Operating Company for the years ending December 2023 and 2024, stating that the figures should be in RMB rather than thousands of RMB. This clarification ensures accurate financial reporting, which is crucial for stakeholders assessing the company’s financial health and strategic acquisitions.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is primarily engaged in providing healthcare solutions in the Chinese market.
YTD Price Performance: 48.15%
Average Trading Volume: 387,364
Technical Sentiment Signal: Hold
Current Market Cap: HK$269.7M
For an in-depth examination of 1011 stock, go to TipRanks’ Stock Analysis page.